PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharma Share News (FARN)

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 250.00
Bid: 240.00
Ask: 260.00
Change: 0.00 (0.00%)
Spread: 20.00 (8.333%)
Open: 250.00
High: 250.00
Low: 250.00
Prev. Close: 250.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Renalytix hails trial results; Kingswood buys JFP

Thu, 01st Dec 2022 21:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Renalytix PLC - London-based diagnostics company focused on kidney health - Notes the results of primary care use of KidneyIntelX in early-stage chronic kidney disease. Reports a 10% improvement in the HBA1c levels in high-risk patients in first six months. Says that 57% of high-risk patients had action taken within 3-months, compared to 35% for low-risk patients. "The impacts of KidneyIntelX early risk assessment, at 90 days and 180 days, are very encouraging as we can now state that we have observed early intervention in the highest risk patients can result in positive clinical outcomes, before kidney disease advances to a critical point. This prospective study in a real-world health care system setting demonstrates that risk-informed care in the earliest stages of chronic kidney disease is not just a vision, it's a reality," Chief Medical Officer Michael Donovan comments.

----------

Fox Marble Holdings PLC - marble quarrying - Says it was awarded EUR383,177 in damages plus GBP454,584 in costs by in the London Court of International Arbitration from its proceedings against a customer based in India. Says no issues remain to be awarded. The amounts awarded bear an interest rate of 8% per year, it says.

----------

Panther Metals PLC - Canada-focused mineral exploration company - Receives the findings of the follow-up geochemical soil sampling programme 1 in the Barker area of the Manitou Lakes project in Ontario, Canada. Identifies a 300-meter strike extent of linear anomalous and high-grade gold in soils at the Barker prospect area. "These results from the latest round of soil geochemical sampling at Manitou Lakes have almost doubled the strike extent of anomalous gold to 700m at the exciting Barker area prospect in the east of the project area," Chief Executive Darren Hazelwood says.

----------

Kingswood Holdings Ltd - London-based wealth and investment management - Buys Cheshire-based financial advisory firm JFP Holdings Ltd. It is the holding company of JFP Financial Services Ltd. Pays a total cash consideration of up to GBP12.4 million, payable over a two-year period. "The acquisition of JFP Holdings will expand our geographical footprint into the Northwest region and an affluent South Manchester area. JFP Holdings are a high-quality business that has operated with its affiliate Josolyne & Co, a leading chartered accountancy practice, for many years," CEO David Lawrence comments.

----------

Synergia Energy Ltd - Perth-based developer of natural gas assets in India, Indonesia and the UK, formerly called Oilex Ltd - Says that gas production from its C-77H well at the Cambay was around average of 270,000 cubic feet per day in November. Says oil production from the field averaged 23 barrels of oil per day for the month.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical-stage biopharmaceutical company - Appoints Maija Hollmen as chief scientific officer. "Hollmen is the world-leading expert on Clever-1 biology and Clever-1-expressing tumour-associated macrophages," Chief Medical Officer Marie-Louise Fjallskog says. "Her support is essential to bexmarilimab's development. Faron is pleased to have her on board in the chief scientific officer role to bring her knowledge of the target molecule and develop it further."

----------

Kropz PLC - African phosphate developer - Says that it agreed to a ZAR121.5 million, or USD7.1 million, bridge loan facility to meet its immediate cash requirements at Elandsfontein. Reports that ZAR242.5 million remains available for drawdown over the term of the ZAR550 million equity facility.

----------

Riverstone Credit Opportunities Income PLC - energy infrastructure and energy-transition credit investor - Realised its investment in Hoover CS with a USD1.6 million gross profit. Also reports an upsized investment in a new sustainability-linked first-lien term loan for Hoover. "Hoover CS has a demonstrated track record of helping its customers across multiple end markets improve environmental performance and the circularity of their supply chains, and we are pleased to partner with them on their next phase of growth. This investment is in-line with our stated yield target and focus on sustainability-linked loans. It also means that RCOI is now almost fully invested," Managing Director Danny Flannery comments.

----------

US Solar Fund PLC - owns and operates solar power assets in North America - Reports changes to key personnel at its investment manager New Energy Solar Manager Pty Ltd. Explains that these changes come amid strategic reviews. Says Liam Thomas will continue to lead the strategic review. Says that Adam Haughton will be leaving NESM in December to pursue an alternative career opportunity. "The board remains fully committed to the strategic review process and is entirely focused on delivering a successful outcome that maximises value for all our shareholders as soon as practically possible. The board would like to wish both Liam and Adam well in their new endeavours and thank them for their commitment to USF since its IPO," Chair Gill Nott says.

----------

Gensource Potash Corp - fertilizer development company based in Saskatchewan, Canada - Plans to raise gross proceeds of CAD6.0 million, or GBP3.6 million, in a non-brokered private placement. The offering will consist of up to 20.0 million units of the company at a price of CAD0.15 per unit. Further, it plans to offer up to 15.0 million common shares at a price of CAD0.20 per flow through share. Intends to use the net proceeds from the sale of the units to advance the Tugaske project.

----------

Atome Energy PLC - Leeds, England-based producer and marketer of green hydrogen and ammonia - Says that it achieved "significant" progress at the Villeta project in Paraguay. Says that its green hydrogen and ammonia Villeta project expanded to a world-scale 120 megawatt capacity capable of producing up to 100,000 metric tonnes of ammonia per year. "We are grateful for the confidence that ANDE [the Paraguayan National Power Company] is showing in Atome by increasing our power supply to 120MW, enabling Paraguay to become the leader on the continent in the fast-growing green hydrogen economy. In parallel, we are announcing that, after a competitive tender process including some of the leading engineers in the field, we have appointed as [front-end engineering design] contractor, a very strong consortium of engineering and industrial companies with a track record of delivering ground-breaking energy projects across Latin America and the world, combined with unparalleled expertise in the ammonia sector," CEO Olivier Mussat comments.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Apr 2023 14:21

Faron Pharmaceuticals test data shows efficacy of bexmarilimab

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said further data from its Phase I/II MATINS study of bexmarilimab has indicated the efficacy and safety of the immunotherapy in solid tumours.

Read more
17 Apr 2023 16:34

TRADING UPDATES: Anglo Asian gold output down; Faron hails antibody

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
29 Mar 2023 10:42

Faron Pharma names James O'Brien, once of Bristol-Myers, as new CFO

(Alliance News) - Faron Pharmaceuticals Ltd on Wednesday said it has appointed James O'Brien as its new chief financial officer, effective from Monday next week, succeeding Toni Hanninen.

Read more
29 Mar 2023 09:38

Faron Pharmaceuticals names James O'Brien as CFO

(Sharecast News) - Drug discovery and development company Faron Pharmaceuticals has tapped James O'Brien to take over as its new chief financial officer.

Read more
22 Mar 2023 17:12

Faron Pharmaceuticals gets positive feedback from FDA meeting

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals said on Wednesday that it had received positive feedback from the US Food and Drug Administration (FDA) on the development of its precision immunotherapy asset 'bexmarilimab'.

Read more
17 Mar 2023 15:42

UK shareholder meetings calendar - next 7 days

Monday 20 March 
Aukett Swanke Group PLCGM re proposed acquisition of Torpedo Factory Group Ltd
Pantheon Resources PLCAGM
Voyager Life PLCGM re subscription and fundraise
Tuesday 21 March 
BlackRock Sustainable American Income Trust PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
React Group PLCAGM
Starvest PLCAGM
Sureserve Group PLCAGM
Wynnstay Group PLCAGM
Zamaz PLCGM re terms and conditions modification
Wednesday 22 March 
abrdn Private Equity Opportunities Trust PLCAGM
Asia Strategic Holdings LtdAGM
Circle Property PLCEGM re final disposal and cancellation
Genel Energy PLCAGM
Harmony Energy Income Trust PLCAGM
Titon Holdings PLCAGM
Thursday 23 March 
Crest Nicholson Holdings PLCAGM
Driver Group PLCAGM
Goldplat PLCAGM
Hardide PLCAGM
Idox PLCAGM
Zaim Credit Systems PLCGM re director removal and name change
Friday 24 March 
Faron Pharmaceuticals LtdAGM
In The Style Group PLCGM re sale of only subsidiary; becoming cash shell named Itsum PLC
Kitwave Group PLCAGM
Midatech Pharma PLCGM re cancellation of the admission to trading on AIM and name change
SME Credit Realisation Fund LtdEGM re cancellation of the company's listing
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
3 Mar 2023 11:53

Faron Pharmaceuticals annual loss widens on higher research costs

(Alliance News) - Faron Pharmaceuticals Ltd on Friday reported a widened loss in 2022 as it ramped up its research & development efforts.

Read more
24 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Monday 27 February 
Associated British Foods PLCTrading Statement
Beeks Financial Cloud Group PLCHalf Year Results
Bunzl PLCFull Year Results
Centralnic Group PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
DX Group PLCHalf Year Results
GlobalData PLCFull Year Results
Greencoat Renewables PLCFull Year Results
Kosmos Energy LtdFull Year Results
Quartix Technologies PLCFull Year Results
RHI Magnesita NVFull Year Results
Senior PLCFull Year Results
Tuesday 28 February 
abrdn PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Bluefield Solar Income Fund LtdHalf Year Results
boohoo Group PLCFull Year Results
Cap-XX LtdHalf Year Results
Croda International PLCFull Year Results
Dalata Hotel Group PLCFull Year Results
Derwent London PLCFull Year Results
Hutchmed (China) LtdFull Year Results
Intertek Group PLCFull Year Results
Kitwave Group PLCFull Year Results
Man Group PLCFull Year Results
McBride PLCHalf Year Results
Morgan Advanced Materials PLCFull Year Results
Ocado Group PLCFull Year Results
Princess Private Equity Holding LtdFull Year Results
Rotork PLCFull Year Results
Serco Group PLCFull Year Results
St James's Place PLCFull Year Results
S-Ventures PLCFull Year Results
Travis Perkins PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Videndum PLCFull Year Results
XP Power LtdFull Year Results
Wednesday 1 March 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
GetBusy PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Global Invacom Group LtdFull Year Results
Haydale Graphene Industries PLCHalf Year Results
International Personal Finance PLCFull Year Results
Nichols PLCFull Year Results
Permanent TSB Group Holdings PLCFull Year Results
Persimmon PLCFull Year Results
Rathbones Group PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Ricardo PLCHalf Year Results
Weir Group PLCFull Year Results
Thursday 2 March 
Alfa Financial Software Holdings PLCFull Year Results
Apax Global Alpha LtdFull Year Results
Beazley PLCFull Year Results
Brooks Macdonald Group PLCHalf Year Results
Cairn Homes PLCFull Year Results
Capita PLCFull Year Results
Capital & Regional PLCFull Year Results
Coats Group PLCFull Year Results
CRH PLCFull Year Results
Flutter Entertainment PLCFull Year Results
Funding Circle Holdings PLCFull Year Results
Grafton Group PLCFull Year Results
Haleon PLCFull Year Results
Hunting PLCFull Year Results
ITV PLCFull Year Results
London Stock Exchange Group PLCFull Year Results
Melrose Industries PLCFull Year Results
Metro Bank PLCFull Year Results
National Express Group PLCFull Year Results
PPHE Hotel Group LtdFull Year Results
Schroder AsiaPacific Fund PLCFull Year Results
Schroders PLCFull Year Results
Spire Healthcare Group PLCFull Year Results
Taylor Wimpey PLCFull Year Results
Tritax Big Box REIT PLCFull Year Results
Tyman PLCFull Year Results
Vesuvius PLCFull Year Results
Friday 3 March 
Avation PLCHalf Year Results
Faron Pharmaceuticals LtdFull Year Results
IMI PLCFull Year Results
Pacific Horizon Investment Trust PLCHalf Year Results
Pearson PLCFull Year Results
Rightmove PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
27 Jan 2023 18:56

TRADING UPDATES: Diaceutics wins two deals; Faron proposes placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
27 Jan 2023 10:28

IN BRIEF: Faron Pharmaceuticals raises EUR12 million via shares

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical drug discovery and development company - Raises EUR12.0 million via placing of 3.7 million shares at the issue price of EUR3.25 each. Faron says that with these proceeds and the current level of activity, it has sufficient working capital into the third quarter of 2023.

Read more
27 Jan 2023 10:11

AIM WINNERS & LOSERS: Faron Pharmaceuticals raises EUR12 million

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
16 Jan 2023 16:26

TRADING UPDATES: Tungsten West 'largest Western tungsten producer'

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2022 12:06

Faron Pharmaceuticals sees patient remission in immunotherapy trials

(Alliance News) - Faron Pharmaceuticals Ltd on Monday said it was encouraged by promising early data from trials for its investigative precision immunotherapy, which aims to provide permanent immune stimulation for difficult-to-treat cancers by targeting myeloid cell function.

Read more
18 Nov 2022 19:49

TRADING UPDATES: Joules nomad resigns; Pharma C loss narrows

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.